4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001209191-22-042675
Chief Development Officer sold 11,444 shares at an average $16.01 ($183,271)
- Chief Development Officer acquired 11,444 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curley Joanne Chief Development Officer | 2022-07-19 | Option exercise | +5,384 | $6.37 | $34,311 | 23,657 | D: show line 1 in the form |
| Curley Joanne Chief Development Officer | 2022-07-19 | Sale | −5,384 | $16.02 | $86,229 | 18,273 | D: show line 2 in the form |
| Curley Joanne Chief Development Officer | 2022-07-19 | Option exercise | +6 | $6.37 | $38 | 18,279 | D: show line 3 in the form |
| Curley Joanne Chief Development Officer | 2022-07-19 | Sale | −6 | $16.55 | $99 | 18,273 | D: show line 4 in the form |
| Curley Joanne Chief Development Officer | 2022-07-19 | Option exercise | +6,046 | $2.90 | $17,514 | 24,319 | D: show line 5 in the form |
| Curley Joanne Chief Development Officer | 2022-07-19 | Sale | −6,046 | $16.01 | $96,810 | 18,273 | D: show line 6 in the form |
| Curley Joanne Chief Development Officer | 2022-07-19 | Option exercise | +8 | $2.90 | $23 | 18,281 | D: show line 7 in the form |
| Curley Joanne Chief Development Officer | 2022-07-19 | Sale | −8 | $16.55 | $132 | 18,273 | D: show line 8 in the form |
| Open-market sales · 11,444 sh · avg $16.01 · $183,271 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curley Joanne Chief Development Officer | 2022-07-19 | Option exercise · Stock Option (right to buy) | −5,390 | 14,029 | D: show line 9 in the form | ||
| Curley Joanne Chief Development Officer | 2022-07-19 | Option exercise · Stock Option (right to buy) | −6,054 | 46,759 | D: show line 10 in the form |
Loading xslF345X03/doc4.xml…